Disruptive healthcare startup raises more than $2.8 million internationally

July 24, 2017

Search for articles by category

Capital investment from international partners from Europe and South East Asia to the tune of over $2.2 million emphasises the high-growth potential of this award-winning healthcare startup.

In addition, they have received more than $500, 000 in grant funding for community projects locally and internationally showcasing the impact of their solutions.

The investment and support from strategic international partners underscores the success of this young social impact startup, acknowledging the value and potential of their innovative digital solutions for healthy hearing.

Since the hearX group launched their flagship product hearScreen™, they have gone to market with several other products including hearZA™, mHealth Studio, hearTest, and hearDigits, as well as a partner product in vision, call Peek Vision.

Their mHealth and cloud-based solutions offer decentralised, low-cost access to ear and hearing care that have reached more than 70 000 people across 25 countries in a short period of time.

Mr Nic Klopper, the CEO of hearX Group, says “These investments will be used to scale existing solutions, research and development of new products, and to gain access to new markets globally”.

With their grant funding, they will spearhead several community-based projects in sub-Saharan Africa in the next 2 years to test up to 100,000 people in communities for hearing and vision loss.

As a social impact startup the hearX vision is to see healthy hearing for everyone, everywhere using connected digital health solutions. Their ambition is to connect 1 million people with healthy hearing and vision services globally by 2020.

In addition, the company is now launching a world-first smartphone device, called hearScope, to look into ears and visualise the eardrum. The crowdfunding lunch will go live on IndieGoGo on 1 August. For more information, visit www.hearscope.io.


For more information on hearX Group, please visit: hearxgroup.com

Disclaimer: The opinions expressed in the publications are those of the authors. They do not reflect the opinions or beliefs of hearX Group or its subsidiaries. The information contained herein is solely for informational purposes. It is not intended to be a substitute for professional medical advice and should not be relied upon as healthcare or medical advice. You are advised to seek guidance from your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking medical advice or care because of the content published herein. If you choose to rely on any information provided by hearX Group or its subsidiaries, you do so entirely at your own risk.

Newsletter

hearX is committed to protecting your privacy and ensuring that personal information is collected and used lawfully and transparently. We use the information provided to contact you about relevant products, services and content. You may unsubscribe at any time. Privacy Policy

Press and mediaPublished researchCareersShipping and returnsPAIA manual
BlogImpact reportsContact usTerms and conditionsPricing
hearX Group info@hearxgroup.com US: +1 (415) 825-3064 RSA: +27 (0) 12 030-0268
Lexie Hearing sales@lexiehearing.com +1 (800) 499-1336
hearX is SOC2® compliant.

This globally recognized attestation validates our commitment to critical security standards to protect and secure client data

FDA Registered | ISO 13485 Certified | SAHPRA Registered | HIPAA Compliant | POPIA Compliant

To report unethical behavior, misconduct or harassment click here.

For any feedback or complaints, please contact: support@hearxgroup.com.

© 2016-2024 hearX IP (Pty) Ltd. Copyright in this work including its layout and the design contained herein is reserved and the making of copies is prohibited.